These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1163 related articles for article (PubMed ID: 8156517)

  • 1. Clinical and histologic involvement of regional lymph nodes in malignant melanoma. Adjuvant vindesine improves survival.
    Retsas S; Quigley M; Pectasides D; Macrae K; Henry K
    Cancer; 1994 Apr; 73(8):2119-30. PubMed ID: 8156517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors prognostic for survival in patients with malignant melanoma spread to the regional lymph nodes.
    Callery C; Cochran AJ; Roe DJ; Rees W; Nathanson SD; Benedetti JK; Elashoff RM; Morton DL
    Ann Surg; 1982 Jul; 196(1):69-75. PubMed ID: 7092355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant treatment with vindesine in comparison to observation alone in patients with metastasized melanoma after complete metastasectomy: a randomized multicenter trial of the German Dermatologic Cooperative Oncology Group.
    Eigentler TK; Radny P; Hauschild A; Gutzmer R; Linse R; Pföhler C; Wagner SN; Schadendorf D; Ellwanger U; Garbe C;
    Melanoma Res; 2008 Oct; 18(5):353-8. PubMed ID: 18781134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged survival of patients receiving active immunotherapy with Canvaxin therapeutic polyvalent vaccine after complete resection of melanoma metastatic to regional lymph nodes.
    Morton DL; Hsueh EC; Essner R; Foshag LJ; O'Day SJ; Bilchik A; Gupta RK; Hoon DS; Ravindranath M; Nizze JA; Gammon G; Wanek LA; Wang HJ; Elashoff RM
    Ann Surg; 2002 Oct; 236(4):438-48; discussion 448-9. PubMed ID: 12368672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant chemotherapy with dacarbazine, vindesine, and cisplatin in pathological stage II malignant melanoma.
    Pectasides D; Alevizakos N; Bafaloukos D; Tzonou A; Asimakopoulos G; Varthalitis I; Dimitriadis M; Athanassiou A
    Am J Clin Oncol; 1994 Feb; 17(1):55-9. PubMed ID: 8311008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial.
    Burmeister BH; Henderson MA; Ainslie J; Fisher R; Di Iulio J; Smithers BM; Hong A; Shannon K; Scolyer RA; Carruthers S; Coventry BJ; Babington S; Duprat J; Hoekstra HJ; Thompson JF
    Lancet Oncol; 2012 Jun; 13(6):589-97. PubMed ID: 22575589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors of overall survival in patients with delayed lymph node dissection for cutaneous malignant melanoma.
    Kretschmer L; Preusser KP; Marsch WC; Neumann C
    Melanoma Res; 2000 Oct; 10(5):483-9. PubMed ID: 11095410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant therapy of malignant melanoma: is there a choice?
    Retsas S
    Crit Rev Oncol Hematol; 2001 Nov; 40(2):187-93. PubMed ID: 11682325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term results of adjuvant chemotherapy after therapeutic lymph node dissection in patients with cutaneous malignant melanoma].
    Kretschmer L; Helmbold P; Emmert S; Marsch WC
    Hautarzt; 2002 Aug; 53(8):536-41. PubMed ID: 12221468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term survival in 2,505 patients with melanoma with regional lymph node metastasis.
    White RR; Stanley WE; Johnson JL; Tyler DS; Seigler HF
    Ann Surg; 2002 Jun; 235(6):879-87. PubMed ID: 12035046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma.
    Agrawal S; Kane JM; Guadagnolo BA; Kraybill WG; Ballo MT
    Cancer; 2009 Dec; 115(24):5836-44. PubMed ID: 19701906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment Outcome and Prognostic Factors for Malignant Skin Melanoma Treated with Radical Surgery.
    Majewski W; Stanienda K; Wicherska K; Ulczok R; Wydmanski J
    Asian Pac J Cancer Prev; 2015; 16(14):5709-14. PubMed ID: 26320440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The number of lymph nodes involved with metastatic disease does not affect outcome in melanoma patients as long as all disease is confined to the sentinel lymph node.
    Jakub JW; Huebner M; Shivers S; Nobo C; Puleo C; Harmsen WS; Reintgen DS
    Ann Surg Oncol; 2009 Aug; 16(8):2245-51. PubMed ID: 19517194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preventive lymph node excision in the treatment concept of melanoma of the extremities].
    Binder J; Henneking K
    Zentralbl Chir; 1996; 121(6):474-7. PubMed ID: 8767334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adjuvant chemotherapy in addition to radical surgical treatment of regional lymph node metastases in malignant melanoma].
    Czarnetzki BM; Aragon V; Bröcker EB; Krieg V; Bünte H; Macher E
    Dtsch Med Wochenschr; 1986 May; 111(19):732-6. PubMed ID: 3698850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of vitamin A versus observation as adjuvant therapy in high-risk primary malignant melanoma: a Southwest Oncology Group study.
    Meyskens FL; Liu PY; Tuthill RJ; Sondak VK; Fletcher WS; Jewell WR; Samlowski W; Balcerzak SP; Rector DJ; Noyes RD
    J Clin Oncol; 1994 Oct; 12(10):2060-5. PubMed ID: 7931474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant postoperative radiotherapy to the cervical lymph nodes in cutaneous melanoma: is there any benefit for high-risk patients?
    Moncrieff MD; Martin R; O'Brien CJ; Shannon KF; Clark JR; Gao K; McCarthy WM; Thompson JF
    Ann Surg Oncol; 2008 Nov; 15(11):3022-7. PubMed ID: 18958539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional control of melanoma neck node metastasis after selective neck dissection with or without adjuvant radiotherapy.
    Hamming-Vrieze O; Balm AJ; Heemsbergen WD; Hooft van Huysduynen T; Rasch CR
    Arch Otolaryngol Head Neck Surg; 2009 Aug; 135(8):795-800. PubMed ID: 19687401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical management of the groin lymph nodes in melanoma in the era of sentinel lymph node dissection.
    Essner R; Scheri R; Kavanagh M; Torisu-Itakura H; Wanek LA; Morton DL
    Arch Surg; 2006 Sep; 141(9):877-82; discussion 882-4. PubMed ID: 16983031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.